Early Viral Load and CD4+T Cell Count, But Not Percentage of CCR5+or CXCR4+CD4+T Cells, Are Associated with R5-to-X4 HIV Type 1 Virus Evolution
- 1 May 2003
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 19 (5) , 389-398
- https://doi.org/10.1089/088922203765551737
Abstract
HIV-1 infection is established by CCR5-utilizing (R5) variants, and CXCR4-utilizing (X4) variants emerge in ~50% of infected patients. We studied the role of CCR5 and CXCR4 expression before and 1 and 5 years after seroconversion in HIV-1 disease in a prospective study of 102 seroconverters. High percentages of CCR5+ cells among total cells (relative hazard [RH], 2.55; 95% confidence interval [95% CI], 0.99-6.52), but not among CD45RO-CD4+ and CD45RO+CD4+ cells preseroconversion and among total cells and CD45RO-CD4+ cells (RH, 2.70; 95% CI, 1.06-6.92 and RH, 3.54; 95% CI, 1.27-9.90, respectively) 5 years after seroconversion were associated with more rapid progression to AIDS. One year after seroconversion, high percentages of CXCR4+ cells among total and CD45RO-CD4+ cells were associated with delayed development of X4 variants (RH, 0.49; 95% CI, 0.20-1.21 and RH, 0.41; 95% CI, 0.17-1.02, respectively), whereas no association was observed for the percentage of CCR5+ cells. In a larger study population, high early serum viral RNA and low CD4+ T cell numbers were associated with more rapid development of X4 variants. Our results exclude target cell availability as a driving force for R5-to-X4 virus phenotype evolution.Keywords
This publication has 60 references indexed in Scilit:
- RANTES Production from CD4+Lymphocytes Correlates with Host Genotype and Rates of Human Immunodeficiency Virus Type 1 Disease ProgressionThe Journal of Infectious Diseases, 2001
- Biological and Genetic Characterization of a Human Immunodeficiency Virus Strain Resistant to CXCR4 Antagonist T134AIDS Research and Human Retroviruses, 2001
- Differential coreceptor expression allows for independent evolution of non–syncytium-inducing and syncytium-inducing HIV-1Journal of Clinical Investigation, 2000
- Inhibition of CXCR4-Dependent HIV-1 Infection by Extracellular HIV-1 TatBiochemical and Biophysical Research Communications, 2000
- Conversion Rate towards a Syncytium‐Inducing (SI) Phenotype during Different Stages of Human Immunodeficiency Virus Type 1 Infection and Prognostic Value of SI Phenotype for Survival after AIDS DiagnosisThe Journal of Infectious Diseases, 1999
- CCR5/Δccr5 Heterozygosity: A Selective Pressure for the Syncytium‐Inducing Human Immunodeficiency Virus Type 1 PhenotypeThe Journal of Infectious Diseases, 1998
- Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4The Journal of Experimental Medicine, 1997
- Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T CellsScience, 1995
- Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission.Journal of Clinical Investigation, 1994
- Associations between HLA Frequencies and Pathogenic Features of Human Immunodeficiency Virus Type 1 Infection in Seroconverters from the Amsterdam Cohort of Homosexual MenThe Journal of Infectious Diseases, 1994